BIT Capital’s Eledon Pharmaceuticals ELDN Stock Holding History

BIT Capital’s Portfolio ELDN Stock Details ELDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05M	Buy	266,000 +132,000	+99%	+$480K	0.03%	78
2026 Q1	$413K	Buy	+134,000	New	+$316K	0.02%	74

Other funds holding ELDN

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

BIT Capital's ELDN Position: Q2 2026 in Review

BIT Capital increased its Eledon Pharmaceuticals (ELDN) stake by 99% in Q2 2026, buying an estimated $480K and bringing the position to 266,000 shares worth $1.05M. The position accounts for 0.03% of the portfolio, ranked #78.

BIT Capital first reported a position in ELDN in Q1 2026 and has held it in 2 quarters since. 160 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

BIT Capital held 266,000 shares of Eledon Pharmaceuticals worth $1.05M as of Q2 2026.
BIT Capital bought 132,000 Eledon Pharmaceuticals shares in Q2 2026, an estimated $480K.
Eledon Pharmaceuticals made up 0.03% of BIT Capital's portfolio in Q2 2026, its #78 holding.
BIT Capital first reported a position in Eledon Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
160 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on BIT Capital's 13F filing for Q2 2026, filed 12 Aug 2026.